Check of Optical Features and Accuracy of the Zeiss ZO Lens After Selection and Calculation With OKULIX
NCT ID: NCT00842959
Last Updated: 2011-06-16
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE4
120 participants
INTERVENTIONAL
2009-02-28
2011-01-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
In the trial the accuracy of prediction of target refraction and the difference between calculated and measured contrast vision will be examined for both lens types.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Evaluation of the Safety & Effectiveness of the Bausch & Lomb AKREOS® TL Intraocular Lens
NCT00838045
Non-comparative Study to Assess the Visual Performances and Safety of a Progressive Multifocal Intraocular Lens
NCT02838004
Wavefront Analysis and Contrast Sensitivity After Cataract Surgery With Akreos Advanced Optics Intraocular Lens Implantation
NCT00863759
Evaluation of the Safety and Effectiveness of the Akreos MI Five-0 Intraocular Lens.
NCT00804726
Clinical Investigation of the Next-Generation Intraocular Lenses
NCT03372434
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
SINGLE_GROUP
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
ZO
XL Stabi ZO or Invent ZO
Invent ZO
monofocal aspheric IOL for implantation into capsular bag
XL Stabi ZO
monofocal aspheric IOL for implantation into capsular bag
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Invent ZO
monofocal aspheric IOL for implantation into capsular bag
XL Stabi ZO
monofocal aspheric IOL for implantation into capsular bag
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Written informed consent of patient after information
Exclusion Criteria
* Limited capacity of understanding
* Diseases that hamper a follow-up examination
* Astigmatism \>2.0 D
* Patients with ocular diseases who may be expected to show a vision of less than 0.63 (decimal) two months after cataract surgery with implantation of intraocular lens
* Complications during surgery, especially complications with positioning of the intraocular lens and with capsulorhexis
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Carl Zeiss Meditec AG
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Acri.Tec GmbH
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Jochen Wahl, MD
Role: PRINCIPAL_INVESTIGATOR
Universitäts-Augenklinik Mainz
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Universitäts-Augenklinik Mainz
Mainz, , Germany
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Acri.Tec-RES-DE-273
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.